Hydrogen Peroxide Biocides: EU Authorization and Obligations for Manufacturers and Distributors

Key data

Manufacturers and distributors of hydrogen peroxide-based biocides have had, since 14 September 2026, a new regulatory framework that simplifies access to the European market, but which also imposes technical and documentary conditions that must be strictly complied with. Implementing Regulation (EU) 2026/2050, published that same day, grants Union authorization for the "Hydrogen peroxide biocidal product family", in accordance with Regulation (EU) No 528/2012 on the marketing and use of biocides.

The key to this centralized authorization is that it eliminates regulatory fragmentation: until now, marketing these products in different EU countries could require separate national procedures. With this single authorization, access is direct to the entire internal market, but under uniform conditions that all operators must respect.

What does this regulation establish?

Implementing Regulation (EU) 2026/2050 establishes the terms under which the hydrogen peroxide-based biocides family is authorized for marketing in the European Union. The central elements of the authorization are as follows:

• Single centralized authorization: Products included in the "Hydrogen peroxide biocidal product family" can be marketed in all Member States without the need for additional individual national authorizations.
• Labeling conditions: Products must comply with the specific labeling requirements established in the regulation, which include information on authorized uses, concentrations and safety warnings.
• Permitted concentrations: The regulation sets the permissible concentrations of hydrogen peroxide for each authorized use within the product family.
• Authorized uses: Only uses expressly covered in the authorization are permitted. Any use outside that scope is not covered by this regulation.
• Technical documentation: Economic operators must review and adapt their safety data sheets and technical product documentation to comply with the terms of this authorization.
• Consequences of non-compliance: Non-compliance with the authorization conditions may result in market withdrawal of the affected products and the imposition of administrative sanctions.

This authorization is part of the Union authorization system provided for in Regulation (EU) No 528/2012, which regulates the marketing and use of biocides throughout the EU. Centralized authorization is the broadest mechanism offered by that system: instead of processing authorizations country by country, a single title valid in all 27 Member States is obtained.

Economic and operational impact

For companies already operating with these products, centralized authorization represents an opportunity for simplification and expansion: with a single authorization title, they can access the entire European internal market without duplicating national administrative procedures.

However, this advantage has an immediate operational cost: adapting technical documentation and labeling to the exact terms of the regulation. The main operational impacts are:

• Review of safety data sheets (SDS): Mandatory for all products in the affected family. SDS must reflect the concentrations and uses authorized by the regulation.
• Label updates: Labels on marketed products must be adjusted to the specific labeling requirements established in the authorization.
• Use verification: Distributors and professional users must confirm that the uses they make of these biocides are within the authorized scope.
• Risk of market withdrawal: Products that do not comply with the authorization conditions may be withdrawn from the market by the competent authorities of any Member State.
• Administrative sanctions: Non-compliance may result in administrative sanctions, the amount of which depends on the legislation of each Member State implementing Regulation (EU) 528/2012.

Who does it affect?

This regulation directly affects all economic operators that manufacture, distribute or professionally use hydrogen peroxide-based biocides in the EU:

• Manufacturers of biocides based on hydrogen peroxide that market products included in the "Hydrogen peroxide biocidal product family".
• Distributors and wholesalers of biocidal products in the chemical and industrial hygiene sector.
• Industrial cleaning companies that use these biocides as part of their processes or services.
• Disinfection companies in sectors such as food, healthcare, hospitality or transport.
• Water treatment companies that use hydrogen peroxide as a biocide in their processes.
• Professional users from any sector that purchase and apply these products in the course of their business.
• Compliance and advisory managers for companies in the chemical, food, healthcare and industrial sectors.

Practical example

A Spanish industrial disinfection company that works with hydrogen peroxide-based biocides and that until now operated only in Spain and France with national authorizations from both countries can, from this centralized authorization, market or provide services in any of the 27 Member States without the need to process new national authorizations.

However, to take advantage of this benefit, the company must act immediately on two fronts: first, verify that its products are actually included in the "Hydrogen peroxide biocidal product family" as defined by Regulation (EU) 2026/2050; and second, update the safety data sheets and labels of all its products to reflect the concentrations permitted and uses authorized by the regulation. If an inspector from any Member State detects that the labeling does not comply with the terms of the authorization, the product may be withdrawn from the market in that country, with the resulting economic and reputational impact.

What should companies do now?

1. Verify if products are included in the authorized family: Check that the hydrogen peroxide biocides that the company manufactures, distributes or uses are within the scope of the "Hydrogen peroxide biocidal product family" defined in Regulation (EU) 2026/2050.
2. Review and update safety data sheets (SDS): Adapt all SDS of the affected products to reflect the permitted concentrations and authorized uses according to the terms of the regulation.
3. Update product labeling: Ensure that labels comply with the specific labeling requirements established in the authorization, including warnings, authorized uses and concentrations.
4. Verify that current uses are within the authorized scope: Review that no use being made of these biocides falls outside the uses expressly covered in the authorization, as those uses are not covered.
5. Update internal technical documentation: Review all technical product documentation to align it with the terms of the authorization and have it available for possible inspections.
6. Inform the distribution chain: Communicate to distributors and professional customers the changes in documentation and labeling to ensure compliance throughout the supply chain.

Official source

Consult complete regulation at official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602050